Pfizer Reaches Landmark Deal with Trump Administration to Lower Medicaid Drug Costs

By Emmanuel Ogbonna Pfizer has reached an agreement with the Trump administration to reduce the cost of prescription drugs for Medicaid patients, a move President Donald Trump hailed Tuesday as a breakthrough in his push to make medications more...

Trump, Pfizer drug pricing deal short on details, possible impact

Dive Brief: Pfizer on Tuesday signed a deal with the Trump administration to offer “most favored nation” drug prices to every state Medicaid program and discounted prices directly to other consumers through a new website. The agreement also...

Trump, Pfizer announce MFN deal; Lilly, others to come

President Trump stood beside Pfizer CEO Albert Bourla in the Oval Office today to announce that Pfizer will offer all of its drugs to Medicaid at prices aligned with what they charge around the world. Pfizer is only the first company to announce a...

EMA Looks to Include Patient Perspectives in Drug Regulation

The European Medicines Agency (EMA) announced on Sept. 29, 2025 that it has published a draft reflection paper on the use of patient experience data in the regulation of drugs (1,2). The reflection paper was written to encourage drug developers to...

Preparing for Pharmaceutical Tariffs: What Industry Can Do To Mitigate Supply Chain Risks

The pharmaceutical industry has benefitted from a generally duty-free import environment for decades, allowing pharmaceutical manufacturers and importers to develop extensive, multi-jurisdictional supply chains optimized for cost, quality,...

Can These 6 Supplements Lower Blood Pressure?

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your individual health, and about any potential drug...

19th World Rabies Day Highlights Vaccination Options

(Vax-Before-Travel News)Since rabies is a viral disease that is almost always fatal following the onset of clinical signs, immediate action is the best solution. 2025 marks the 19th World Rabies Day with the theme "Act Now: You, Me, Communities."...

Probe begins after children die of 'toxic' cough syrup

India's drug regulatory authority has initiated a probe as several children died after taking "toxic" cough syrup in various parts of Rajasthan. "The state is carrying out an investigation. The samples have been sent for testing at Rajasthan...

Thomas Crawford, MD, talks advancements for spinal muscular atrophy treatment

The pivotal phase 3 SAPPHIRE trial has provided the strongest evidence to date that apitegromab, an investigational myostatin inhibitor, can improve motor function in children with spinal muscular atrophy (SMA) who continue to experience weakness...

Most States Are Green with Influenza Cases

(Vax-Before-Travel News)The US CDC recently published its Weekly US Influenza Surveillance Report: Key Updates for Week 38 of 2025, which indicates very few influenza cases have been reported this season. As of late September, the percentage of...

Startup Crystalys Therapeutics Emerges With $205M to Fill a Growing Gap in Gout Treatment

In gout, the drug choices for patients remain limited. The history of this field includes many molecules that fell short in the clinic or on the market for safety reasons. James Mackay knows firsthand having led a company that developed two of...

<![CDATA[Mytesi Seeks FDA Orphan Drug Designation in Breast Cancer Diarrhea]]>

Napo Pharmaceuticals has submitted an orphan drug designation application to the U.S. Food and Drug Administration (FDA) for novel prescription drug Mytesi (crofelemer) for the treatment of diarrhea among adult patients with breast cancer that has...

Bayer seeks approval for key heart drug in India

San Sebastian (Spain): Pharmaceutical major Bayer has filed for approval to market its patented drug finerenone in India for treating certain heart failure patients, a potential boost in a country increasingly grappling with early onset of heart...

Green team get hands-on for community

A ground force from Cemex has given biodiversity a boost at New Bilton's Jubilee Recreation Ground and Gladstone Green. The team from Cemex's Rugby Cement Plant joined forces with the council's parks and open spaces team to carry out the work,...

Secrets of Shoulder Health for Wheelchair Users

Illustration by Doug Davis One day last fall, I was out mountain biking, and my dog stopped in front of me on a sloped turn. I flipped my bike trying to avoid her, fell to the bottom of the bank and landed hard on my left shoulder. After a string...

Ozempic: Sexual Effects — For Better or Worse?

Some people who have taken GLP-1 medications have said on social media that they have noticed an increase in penis size, weakness in vaginal muscles, or vaginal looseness. Szoke says that GLP-1 medications will not change the size of your sexual...

Gavi-supported immunizations saved record lives in 2024

In a progress report covering its activities in 2024, Gavi, the Vaccine Alliance, today reported that Gavi-supported vaccines saved a record 1.7 million lives, 400,000 more than in 2023. In a statement, the group also reported major progress in...

<![CDATA[Safe Food Practices at Home for Immunocompromised Patients With Cancer ]]>

Heather Ann Yonker, outpatient stem cell transplant dietitian at John Theurer Cancer Center in Hackensack, New Jersey, expands on practical strategies for maintaining food safety in the home kitchen, particularly for patients with compromised...

<![CDATA[FDA Approves Remibrutinib, First Oral BTK Inhibitor for CSU]]>

The US Food and Drug Administration (FDA) has approved remibrutinib (Rhapsido; Novartis), an oral Bruton’s tyrosine kinase inhibitor (BTKi), for the treatment of adult patients with chronic spontaneous urticaria (CSU) who remain symptomatic...

Dr Fungus: A New App Bringing Fungal Education to Your Fingertips

An app to learn more about fungi and antifungal treatments? There is an app for that. Matthew Pullen, MD, assistant professor at the University of Minnesota and a member of the Infection Control Today® (ICT®) Editorial Advisory Board, returns to...